(Q40174128)

18 September 2017

1 reference

title

Limitations of current antimicrobial therapy in the immunosuppressed host: looking at both sides of the coin (English)

1 reference

18 September 2017

Limitations of current antimicrobial therapy in the immunosuppressed host: Looking at both sides of the coin (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

10 October 2023

1 reference

P. A. Pizzo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6369974

10 October 2023

L. S. Young

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6369974

10 October 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

18 September 2017

30 March 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6369974

full work available at URL

10 October 2023

https://api.elsevier.com/content/article/PII:0002934384903279?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

https://api.elsevier.com/content/article/PII:0002934384903279?httpAccept=text/plain

10 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

American Journal of Medicine

10 October 2023

published in

1 reference

18 September 2017

volume

76

1 reference

18 September 2017

issue

3A

1 reference

18 September 2017

page(s)

101-110

1 reference

Empiric antibiotic therapy

18 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Improved prognosis for granulocytopenic patients with gram-negative bacteremia

10 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Increasing incidence of Gram-positive sepsis in cancer patients

10 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

10 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection

10 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy

10 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Bacteremia due to methicillin-resistant Staphylococcus aureus

10 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit

10 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Alpha-hemolytic streptococci: clinical significance in the cancer patient

10 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Sepsis with a new species of Corynebacterium

10 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Infection Due to Corynebacterium Species in Marrow Transplant Patients

10 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Tuberculosis complicating neoplastic disease.A review of 201 cases

10 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Mycobacteriosis in Patients With Malignant Disease

10 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Mycobacterium avium-intracellulare: A Cause of Disseminated Life-Threatening Infection in Homosexuals and Drug Abusers

10 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Infectious Complications Associated with Hairy Cell Leukemia

10 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Fungal infections in patients with acute leukemia

10 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Aspergillosis of the nervous system

10 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy

10 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Aspergillosis of the nose and paranasal sinuses

10 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

10 October 2023

Mucormycosis

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization

10 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Invasive Aspergillosis in Renal Transplant Recipients: Correlation with Corticosteroid Therapy

10 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Colonization and infection with Trichosporon species in the immunosuppressed host

10 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Histoplasmosis in immunosuppressed patients

10 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species.

10 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

10 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction

10 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

The New England Journal of Medicine

10 October 2023

39

306

248

1982

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission

10 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections

10 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus Infection

10 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation

10 October 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

A Prospective Analysis of Interstitial Pneumonia and Opportunistic Viral Infection among Recipients of Allogeneic Bone Marrow Grafts

10 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Infectious Complications of Human Bone Marrow Transplantation

10 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' Experience

10 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon

10 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Treatment of cytomegalovirus pneumonia with high-dose acyclovir

10 October 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Toxicity and Efficacy of Human Leukocyte Interferon for Treatment of Cytomegalovirus Pneumonia after Marrow Transplantation

10 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Cytomegalovirus Immune Plasma in Bone Marrow Transplant Recipients

10 October 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

10 October 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: A prospective study

10 October 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Herpesvirus infection of the esophagus and other visceral organs in adults. Incidence and clinical significance

10 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

10 October 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host

10 October 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Acyclovir prophylaxis of herpes-simplex-virus infections

10 October 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

10 October 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Cephalosporin antibiotics

10 October 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia

10 October 2023

62

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics

10 October 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Approaching the controversies in antibacterial management of cancer patients

10 October 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Effect of adenine arabinoside on severe Herpesvirus hominis infections in man

10 October 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients

10 October 2023

67

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

10 October 2023

68

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Varicella in children with cancer: Seventy-seven cases

10 October 2023

69

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

10 October 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients

10 October 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia

10 October 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Infections in cancer patients on a protected environment-prophylactic antibiotic program

10 October 2023

74

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis

10 October 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia

10 October 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Colonization resistance of the digestive tract in conventional and antibiotic-treated mice

10 October 2023

82

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

10 October 2023

84

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients

10 October 2023

85

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Co-trimoxazole for prevention of infection in acute leukaemia

10 October 2023

86

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia

10 October 2023

87

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial

10 October 2023

88

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia

10 October 2023

89

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

10 October 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

10 October 2023

92

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trial

10 October 2023

93

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Inhibition of isolation of Escherichia coli in blood cultures by trimethoprim-sulfamethoxazole

10 October 2023

94

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis

10 October 2023

96

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia

10 October 2023

97

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections

10 October 2023

98

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease

10 October 2023

100

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Response of Patients with Hodgkin's Disease to Pneumococcal Vaccine

10 October 2023

101

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis

10 October 2023

102

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Treatment and Prevention of Intravascular Coagulation with Antiserum to Endotoxin

10 October 2023

105

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

10 October 2023

106

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Modulation of human hematopoiesis by prostaglandins and lithium

10 October 2023

107

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

10 October 2023

Lithium and leukocytosis

108

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

In vivo stimulation of murine granulopoiesis by human urinary extract from patients with aplastic anemia

10 October 2023

110

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

Lithium enhances growth of human leukaemia cells in vitro

10 October 2023

111

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90327-9

10 October 2023

Identifiers

1 reference

18 September 2017

1 reference